| |
|
|
|
Management Team
Marvin H. Caruthers, Ph.D.,
is the Distinguished Professor of Chemistry
and Biochemistry at the University of Colorado. Dr. Caruthers is
a renowned research scientist in the field of DNA Synthesis, and
an inventor and multiple patent holder of key enabling manufacturing
techniques for the biotechnology industry.
In 1980, Dr. Caruthers
and seven other research scientists founded AMGEN with three venture
capital groups. AMGEN is now the largest biotechnology company in
the world with revenues of $6 billion and a market capitalization
exceeding $60 billion. Dr. Caruthers continues to serve as a scientific
consultant to the company.
Dr.
Caruthers and Dr. Lee Hood co-founded Applied Biosystems, Inc.,
in 1981 to commercialize their discoveries in the chemical synthesis
of nucleic acids and the sequencing of proteins. Applied Biosystems,
the worldwide leader in this field, was acquired by Perkin Elmer
Corporation in 1991 for $450 million. Together with BV General
Partner Kyle Lefkoff, he is a founding investor in Genomica, Array
BioPharma and Dharmacon.
Dr. Caruthers, a Guggenheim Fellow,
received his Ph.D. in Biochemistry from Northwestern University,
and completed his post-doctoral studies at MIT. He is an Editorial
Board member of the Journal of Biotechnology, the Journal of Protein
Engineering, and the Journal of Molecular Recognition. Dr. Caruthers
is a Member of the National Academy of Sciences and of the American
Academy of Arts & Sciences.
He has been a Venture Partner with Boulder Ventures since its founding
in 1995. Dr. Caruthers resides in Boulder, Colorado.
|
|
|